Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mauro David J
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khan Najat
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
No Data